A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma.
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma. Cancer Chemother Pharmacol. 2010 Feb; 65(3):509-14.